newsfilter
← Latest News
ACCESS Newswire·

NeonMind Provides Integrated Drug Development Plan Update for NEO-001 to Treat Obesity

Target Product Profile and Clinical Phase 1/2 Study Aim To Address Deficiencies In Chronic Weight Management Pre-IND Meeting in the U.S. and Pre-CTA Consultation Meeting in Canada Targeted for 4Q2021 Initiation of Phase 1/2 Clinical Proof of Concept S